These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20068480)

  • 1. SB203580, a p38 inhibitor, improved cardiac function but worsened lung injury and survival during Escherichia coli pneumonia in mice.
    Su J; Cui X; Li Y; Mani H; Ferreyra GA; Danner RL; Hsu LL; Fitz Y; Eichacker PQ
    J Trauma; 2010 Jun; 68(6):1317-27. PubMed ID: 20068480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of p38 map kinase inhibits complement-induced acute lung injury in a murine model.
    Nash SP; Heuertz RM
    Int Immunopharmacol; 2005 Dec; 5(13-14):1870-80. PubMed ID: 16275622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of an immune suppressive macrophage phenotype as a product of P38 MAPK activation in polymicrobial sepsis.
    Song GY; Chung CS; Jarrar D; Chaudry IH; Ayala A
    Shock; 2001 Jan; 15(1):42-8. PubMed ID: 11198356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages.
    Kim HJ; Lee HS; Chong YH; Kang JL
    Toxicology; 2006 Aug; 225(1):36-47. PubMed ID: 16793190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38 Inhibition Ameliorates Inspiratory Resistive Breathing-Induced Pulmonary Inflammation.
    Toumpanakis D; Vassilakopoulou V; Mizi E; Chatzianastasiou A; Loverdos K; Vraila I; Perlikos F; Tsoukalas D; Giannakopoulou CE; Sotiriou A; Dettoraki M; Karavana V; Vassilakopoulos T
    Inflammation; 2018 Oct; 41(5):1873-1887. PubMed ID: 29974374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of p38 mitogen-activated protein kinase in lung injury after burn trauma.
    Chen XL; Xia ZF; Ben DF; Wang GQ; Wei D
    Shock; 2003 May; 19(5):475-9. PubMed ID: 12744493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart.
    Surinkaew S; Kumphune S; Chattipakorn S; Chattipakorn N
    J Cardiovasc Pharmacol; 2013 Feb; 61(2):133-41. PubMed ID: 23107875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous intrathecal infusion of SB203580, a selective inhibitor of p38 mitogen-activated protein kinase, reduces the damage of hind-limb function after thoracic spinal cord injury in rat.
    Horiuchi H; Ogata T; Morino T; Chuai M; Yamamoto H
    Neurosci Res; 2003 Oct; 47(2):209-17. PubMed ID: 14512145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model.
    Zhou WD; Yang HM; Wang Q; Su DY; Liu FA; Zhao M; Chen QH; Chen QX
    Hum Reprod; 2010 Dec; 25(12):3110-6. PubMed ID: 20956267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical.
    Mocanu MM; Baxter GF; Yue Y; Critz SD; Yellon DM
    Basic Res Cardiol; 2000 Dec; 95(6):472-8. PubMed ID: 11192368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p38 MAPK activation protects cardiac mitochondria from ischemia/reperfusion injury.
    Kumphune S; Surinkaew S; Chattipakorn SC; Chattipakorn N
    Pharm Biol; 2015; 53(12):1831-41. PubMed ID: 25880145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
    Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
    Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SB203580 reverses adrenomedullin's effect on proliferation and apoptosis in cultured mesangial cells.
    Parameswaran N; Spielman WS; Brooks DP; Nambi P
    Eur J Pharmacol; 1999 Apr; 371(1):75-82. PubMed ID: 10355597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of phosphorylated mitogen-activated protein kinases on phosgene inhalation-induced lung injury in rats and its relationship with matrix metalloproteinase].
    Shao YR; Shen J; Li W; Yuan Z; He DK
    Zhonghua Shao Shang Za Zhi; 2013 Jun; 29(3):261-6. PubMed ID: 24059951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of p38 mitogen activated protein kinase inhibitor SB203580 on colonic mucosa tumor necrosis factor alpha expression in ulcerative colitis].
    Yi WQ; Gan HT; Huang XL; Zhang M; Ouyang Q
    Zhonghua Nei Ke Za Zhi; 2007 Sep; 46(9):747-50. PubMed ID: 18028805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils.
    Coxon PY; Rane MJ; Uriarte S; Powell DW; Singh S; Butt W; Chen Q; McLeish KR
    Cell Signal; 2003 Nov; 15(11):993-1001. PubMed ID: 14499342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes.
    Henklova P; Vrzal R; Papouskova B; Bednar P; Jancova P; Anzenbacherova E; Ulrichova J; Maurel P; Pavek P; Dvorak Z
    Eur J Pharmacol; 2008 Sep; 593(1-3):16-23. PubMed ID: 18655782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.
    Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS
    Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.